Clinical trial
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen…
NCT00133146 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00133146 |
|---|---|
| Title | Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine |
| Official title | Double-Blind Phase 2a Study to Demonstrate the Contribution of MPL to Tyrosine Adsorbed Grass/Rye Pollen Allergoid With a Single-Blind Portion to Evaluate Residual Allergenicity in Skin Test in Volunteers Allergic to Grass & Rye Pollen |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Grass MATA MPL |
| Enrollment | 41 |
| Start date | Sep 12, 2005 |
| Primary completion | Nov 23, 2005 |
| Completion | Nov 23, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | Jul 13, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: